Michael Lidsky, MD, FACS

Surgical Oncologist and Hepatopancreatobiliary Surgeon @DukeSurgery, Basic and Translational Surgeon-Scientist @DukeUniversity @DukeSurgOnc

[Duke Surgical Oncology @DukeSurgOnc]

Congrats to our @DukeSurgRes alum and current @MSKCancerCenter surgical oncology fellow, Dr. @eckhoff_austin! Outstanding!

@SocSurgOnc

[ECOG-ACRIN Cancer Research Group @eaonc]

In #ClinicalTrial EA2222/PUMP, investigators are testing #PumpChemo in addition to SOC chemo versus SOC chemo alone for patients with unresectable #ColorectalCancer liver metastases. For more: https://t.co/xBChV6GALe cc: @michael_lidsky

[Duke Cancer @DukeCancer]

Research led by DCI's Jennifer Plichta, MD, suggests that some patients with limited metastatic breast cancer may benefit from a more aggressive treatment approach than has traditionally been offered.

https://t.co/h5kbLlrt3f

#BreastCancer | @DukeMedSchool | @DukeHealth

[Duke Surgical Oncology @DukeSurgOnc]

🎉 Congratulations to our graduating fellows! We’re proud of all you’ve accomplished!

🔹 Dr. Brittany Sullivan→ Surgical Oncology, @UofUHealth
🔹 Dr. Anna Louie→ Breast Surgical Oncology, @UnivOfKansas
🔹 Dr. Kristin Trone→ Endocrine Surgery, @aboutKP

#SurgOnc #Fellows

[ECOG-ACRIN Cancer Research Group @eaonc]

#ClinicalTrial EA2222/PUMP, led by @michael_lidsky, is a randomized phase 3 study of #SystemicTherapy with or without hepatic arterial infusion for unresectable #Colorectal liver metastases. More here: https://t.co/xBChV6GALe cc: @MichaelDAngeli2, @skmaithel, @AndreaCercek

[ECOG-ACRIN Cancer Research Group @eaonc]

#ClinicalTrial EA2222/PUMP, led by @michael_lidsky, is a randomized phase 3 study of #SystemicTherapy with or without hepatic arterial infusion for unresectable #Colorectal liver metastases. More here: https://t.co/xBChV6GALe

[ECOG-ACRIN Cancer Research Group @eaonc]

.@michael_lidsky of @DukeSurgOnc and @DukeCancer is leading EA2222/PUMP, a randomized phase 3 study for patients with #Colorectal liver metastases. Learn more: https://t.co/xBChV6GALe cc: @CCAlliance, @FightCRC, @NCCRTnews

[Michael Lidsky, MD, FACS @michael_lidsky]

Amazing @JenniferPlichta !!

[Duke Surgical Oncology @DukeSurgOnc]

Dr. Jennifer Plichta has been awarded a ⭐️ R01 grant ⭐️for her project addressing a lack of prognostic staging systems for patients with recurrent breast cancer. Congratulations, Dr. Plichta! 🤩🤩🤩 We cannot be more proud of her!!! @JenniferPlichta @DukeCancer @DukeSurgery

[ECOG-ACRIN Cancer Research Group @eaonc]

.@michael_lidsky of @DukeSurgOnc and @DukeCancer is leading EA2222/PUMP, a randomized phase 3 study for patients with #Colorectal liver metastases. Learn more: https://t.co/xBChV6GALe cc: @CCAlliance, @FightCRC, @NCCRTnews

[Society of Surgical Oncology @SocSurgOnc]

We are pleased to announce that @SurgOncInsight has received its inaugural Journal Impact Factor of 1.0. 🎉

Thank you for helping establish SOI as a trusted source of innovative surgical oncology research. Read more:

[Michael Lidsky, MD, FACS @michael_lidsky]

Congrats @blazer_trey

[Duke Surgery @DukeSurgery]

We are pleased to announce that Dr. Trey Blazer, has been appointed Vice Chair of Faculty Affairs for the Department of Surgery, effective July 1. Dr. Blazer is a Professor of Surgery and currently serves as Interim Chief of @DukeSurgOnc.

Read more: https://t.co/ljJPFcp5eb

[ECOG-ACRIN Cancer Research Group @eaonc]

In #ClinicalTrial EA2222/PUMP, investigators are testing #PumpChemo in addition to SOC chemo versus SOC chemo alone for patients with unresectable #ColorectalCancer liver metastases. For more: https://t.co/xBChV6GALe cc: @michael_lidsky

[Michael Lidsky, MD, FACS @michael_lidsky]

Amazing! Congrats @annieliu90 and Clark Howell! @DukeSurgRes @DukeSurgOnc @DukeSurgery @UTMDAnderson

[Duke Surgical Oncology @DukeSurgOnc]

🎉 Congratulations to Duke Surgery residents Dr. Annie Liu & Dr. Clark Howell on matching into CGSO fellowships at @DukeSurgOnc and @UTMDAnderson! We are so proud of you! #SurgOnc #CGSOMatch @DukeSurgRes @SocSurgOnc

[ECOG-ACRIN Cancer Research Group @eaonc]

.@michael_lidsky of @DukeSurgOnc and @DukeCancer is leading EA2222/PUMP, a randomized phase 3 study for patients with #Colorectal liver metastases. Learn more: https://t.co/xBChV6GALe cc: @CCAlliance, @FightCRC, @NCCRTnews

[Michael Lidsky, MD, FACS @michael_lidsky]

Congrats @cutitoutdave on your new role @UMichSurgery . Was a great time working with and learning from you @DukeSurgery for the past 8 years.

[Michigan Surgery @UMichSurgery]

Delighted to introduce the Section of Plastic Surgery's newest faculty member: David A. Brown, MD, PhD.

Welcome to the Department of Surgery, Dr. Brown!

[ECOG-ACRIN Cancer Research Group @eaonc]

.@michael_lidsky of @DukeSurgOnc and @DukeCancer is leading EA2222/PUMP, a randomized phase 3 study for patients with #Colorectal liver metastases. Learn more: https://t.co/xBChV6GALe cc: @CCAlliance, @FightCRC, @NCCRTnews

[Michael Lidsky, MD, FACS @michael_lidsky]

This will be great! @blazer_trey @DukeSurgOnc @DukeSurgery @DukeCancer

[Society of Surgical Oncology @SocSurgOnc]

Don’t miss the next CGSO Videoconference focused on Gastric cases. Hear live presentations from CGSO Fellows and expert insights from Dan Blazer III (Trey), MD, FACS, on Wednesday, June 10 at 5:30 PM CST.

Secure your spot: https://t.co/Vetu0BhR2H

[Duke Cancer @DukeCancer]

🎉 Congratulations to DCI's Daniel George, MD, for being named a 2026 Giant of Cancer Care in Genitourinary Cancer! This award celebrates the visionaries who have transformed the landscape of oncology.

https://t.co/ID6Eyko0IQ

@DukeHealth | @MJHLifeSciences | @DukeGUCancer

[ECOG-ACRIN Cancer Research Group @eaonc]

In #ClinicalTrial EA2222/PUMP, investigators are testing #PumpChemo in addition to SOC chemo versus SOC chemo alone for patients with unresectable #ColorectalCancer liver metastases. For more: https://t.co/xBChV6GALe cc: @michael_lidsky

[Michael Lidsky, MD, FACS @michael_lidsky]

Amazing turnout for the 36th Hilliard Seigler Duke Melanoma and Skin Cancer Consortium! Congrats Georgia Beasley and April Salama for putting together an outstanding program! @DukeSurgOnc @DukeCancer @DukeSurgery